Logo image of ABO.DE

CLEARVISE AG (ABO.DE) Stock Fundamental Analysis

FRA:ABO - Deutsche Boerse Ag - DE000A1EWXA4 - Common Stock - Currency: EUR

1.68  -0.01 (-0.59%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ABO. ABO was compared to 20 industry peers in the Independent Power and Renewable Electricity Producers industry. While ABO belongs to the best of the industry regarding profitability, there are concerns on its financial health. ABO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ABO was profitable.
In multiple years ABO reported negative net income over the last 5 years.
Each year in the past 5 years ABO had a positive operating cash flow.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

1.2 Ratios

The Return On Assets of ABO (2.23%) is better than 65.00% of its industry peers.
Looking at the Return On Equity, with a value of 5.28%, ABO is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
ABO has a Return On Invested Capital of 5.26%. This is amongst the best in the industry. ABO outperforms 85.00% of its industry peers.
ABO had an Average Return On Invested Capital over the past 3 years of 3.36%. This is in line with the industry average of 3.98%.
The last Return On Invested Capital (5.26%) for ABO is above the 3 year average (3.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.23%
ROE 5.28%
ROIC 5.26%
ROA(3y)1.73%
ROA(5y)1.25%
ROE(3y)4.2%
ROE(5y)3.42%
ROIC(3y)3.36%
ROIC(5y)3.36%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

ABO has a Profit Margin of 11.75%. This is in the better half of the industry: ABO outperforms 65.00% of its industry peers.
In the last couple of years the Profit Margin of ABO has grown nicely.
ABO has a Operating Margin of 30.43%. This is in the better half of the industry: ABO outperforms 80.00% of its industry peers.
ABO's Operating Margin has improved in the last couple of years.
ABO's Gross Margin of 95.24% is amongst the best of the industry. ABO outperforms 95.00% of its industry peers.
ABO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 30.43%
PM (TTM) 11.75%
GM 95.24%
OM growth 3Y-2.84%
OM growth 5Y2.37%
PM growth 3Y32.86%
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.98%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

3

2. Health

2.1 Basic Checks

ABO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ABO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ABO has been increased compared to 5 years ago.
The debt/assets ratio for ABO has been reduced compared to a year ago.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ABO has an Altman-Z score of 0.90. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.90, ABO perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
ABO has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
ABO has a Debt to Equity ratio (1.00) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACC1.23
WACC4.28%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.17 indicates that ABO should not have too much problems paying its short term obligations.
ABO's Current ratio of 1.17 is on the low side compared to the rest of the industry. ABO is outperformed by 65.00% of its industry peers.
A Quick Ratio of 1.17 indicates that ABO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.17, ABO is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

3

3. Growth

3.1 Past

The earnings per share for ABO have decreased strongly by -73.01% in the last year.
Measured over the past years, ABO shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.96% on average per year.
The Revenue for ABO has decreased by -31.18% in the past year. This is quite bad
Measured over the past years, ABO shows a small growth in Revenue. The Revenue has been growing by 7.20% on average per year.
EPS 1Y (TTM)-73.01%
EPS 3Y21.96%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-31.18%
Revenue growth 3Y7.15%
Revenue growth 5Y7.2%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ABO will show a very negative growth in Earnings Per Share. The EPS will decrease by -31.24% on average per year.
ABO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.58% yearly.
EPS Next Y-138.86%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
EPS Next 5Y-31.24%
Revenue Next Year-17.04%
Revenue Next 2Y-0.63%
Revenue Next 3Y3.92%
Revenue Next 5Y4.58%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

2

4. Valuation

4.1 Price/Earnings Ratio

ABO is valuated correctly with a Price/Earnings ratio of 15.27.
ABO's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.25, ABO is valued a bit cheaper.
The Forward Price/Earnings Ratio is negative for ABO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 15.27
Fwd PE N/A
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABO is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.05
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The decent profitability rating of ABO may justify a higher PE ratio.
A cheap valuation may be justified as ABO's earnings are expected to decrease with -32.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.55%, ABO has a reasonable but not impressive dividend return.
ABO's Dividend Yield is a higher than the industry average which is at 3.80.
ABO's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 3.55%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M 25M

CLEARVISE AG

FRA:ABO (5/30/2025, 7:00:00 PM)

1.68

-0.01 (-0.59%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)05-09 2025-05-09
Earnings (Next)08-15 2025-08-15
Inst Owners5.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap126.60M
Analysts85
Price Target3.2 (90.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.05%
PT rev (3m)-5.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.27
Fwd PE N/A
P/S 1.75
P/FCF N/A
P/OCF N/A
P/B 0.79
P/tB 0.79
EV/EBITDA 7.05
EPS(TTM)0.11
EY6.55%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.96
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 5.28%
ROCE 6.47%
ROIC 5.26%
ROICexc 5.89%
ROICexgc 5.89%
OM 30.43%
PM (TTM) 11.75%
GM 95.24%
FCFM N/A
ROA(3y)1.73%
ROA(5y)1.25%
ROE(3y)4.2%
ROE(5y)3.42%
ROIC(3y)3.36%
ROIC(5y)3.36%
ROICexc(3y)4.06%
ROICexc(5y)3.9%
ROICexgc(3y)4.12%
ROICexgc(5y)3.99%
ROCE(3y)4.14%
ROCE(5y)4.13%
ROICexcg growth 3Y-12.43%
ROICexcg growth 5Y0.76%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y1.65%
OM growth 3Y-2.84%
OM growth 5Y2.37%
PM growth 3Y32.86%
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.98%
F-ScoreN/A
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 0.9
F-ScoreN/A
WACC4.28%
ROIC/WACC1.23
Cap/Depr(3y)80.88%
Cap/Depr(5y)48.91%
Cap/Sales(3y)30.59%
Cap/Sales(5y)18.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.01%
EPS 3Y21.96%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-138.86%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
EPS Next 5Y-31.24%
Revenue 1Y (TTM)-31.18%
Revenue growth 3Y7.15%
Revenue growth 5Y7.2%
Sales Q2Q%N/A
Revenue Next Year-17.04%
Revenue Next 2Y-0.63%
Revenue Next 3Y3.92%
Revenue Next 5Y4.58%
EBIT growth 1Y-65.91%
EBIT growth 3Y4.1%
EBIT growth 5Y9.75%
EBIT Next Year71.88%
EBIT Next 3Y31.9%
EBIT Next 5Y23.8%
FCF growth 1Y-26.38%
FCF growth 3Y-14.34%
FCF growth 5Y6.36%
OCF growth 1Y-66.66%
OCF growth 3Y-13.84%
OCF growth 5Y-5.59%